PRELUDE CAPITAL MANAGEMENT, LLC
Follow13F filer, CIK 1387508, NEW YORK, NY
PRELUDE CAPITAL MANAGEMENT, LLC reported $1,028,365,365 across 975 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14. Its ten largest share positions make up 14.09% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000945621-25-000769
- Period
- 2025-06-30
- Reported value
- $1.03B
- Holdings
- 975
- Top 10 weight
- 14.09%
- New
- 336
- Sold out
- 504
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| METAadded | +19,944 | $14.7M |
| GOOGnew | +65,723 | $11.7M |
| NVDAadded | +69,343 | $11M |
| HYGadded | +131,561 | $10.6M |
| TSLAadded | +33,050 | $10.5M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| AVGOreduced | -42,977 | -$11.8M |
| CORZreduced | -635,191 | -$10.8M |
| INTRA-CELLULAR THERAPIES INCexited | -79,142 | -$10.4M |
| GOOGLreduced | -52,998 | -$9.34M |
| ORCLreduced | -41,758 | -$9.13M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Back to all 969 share positions
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| IBITISHARES BITCOIN TRUST ETF SHS | call | 1,700 | $2.28M | -145,800 |
| SPYSTATE STR SPDR S&P 500 ETF T SHS | call | 542 | $461K | -78,658 |
| SPYSTATE STR SPDR S&P 500 ETF T SHS | put | 1,436 | $325K | -86,664 |
| NVDANVIDIA CORPORATION COM | put | 907 | $246K | -80,593 |
| XLPSELECT SECTOR SPDR TR STATE STREET CON | put | 925 | $222K | -93,275 |
| SESEA LTD SPONSORD ADS | put | 195 | $213K | -17,705 |
Sold out in Q2 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| ONDSONDAS INC | 11,006 | $11.8K | shares |
| BIODESIX INCBIODESIX INC | 11,706 | $7.32K | shares |
| ATHIRA PHARMA INCATHIRA PHARMA INC | 11,000 | $3.13K | shares |
| SRZNWSURROZEN INC | 24,614 | $738 | shares |
How Q2 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000945621-25-000769 | base | 2025-08-14 | acceptance time not in the bulk data set |